PALO ALTO, Calif.--(BUSINESS WIRE)--Researchers at Lucile Packard Children’s Hospital and Stanford University are studying the safety and effectiveness of a new atypical anti-psychotic medication to improve behavioral problems such as agitation and aggression in children with autism. This medication has been approved by the Food and Drug Administration (FDA) for the treatment of adult individuals with bipolar disorder and schizophrenia. In order to participate in this research study, children must:
